DFP00173
CAS No. 672286-03-2
DFP00173( —— )
Catalog No. M26152 CAS No. 672286-03-2
DFP00173 is a potent and selective aquaporin 3 (AQP3) inhibitor. DFP00173 inhibits mouse and human AQP3 with IC50 of ~0.1-0.4 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 167 | In Stock |
|
| 5MG | 152 | In Stock |
|
| 10MG | 238 | In Stock |
|
| 25MG | 389 | In Stock |
|
| 50MG | 531 | In Stock |
|
| 100MG | 747 | In Stock |
|
| 200MG | 1014 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDFP00173
-
NoteResearch use only, not for human use.
-
Brief DescriptionDFP00173 is a potent and selective aquaporin 3 (AQP3) inhibitor. DFP00173 inhibits mouse and human AQP3 with IC50 of ~0.1-0.4 μM.
-
DescriptionDFP00173 is a potent and selective aquaporin 3 (AQP3) inhibitor. DFP00173 inhibits mouse and human AQP3 with IC50 of ~0.1-0.4 μM. Compared with the homologous AQP subtypes AQP7 and AQP9, DFP00173 is selective for AQP3.(In Vitro):DFP00173 inhibits the glycerol permeability of human red blood cells with IC50 of ~0.2 μM.
-
In VitroDFP00173 inhibits the glycerol permeability of human erythrocytes with an IC50 of ~0.2 μM.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number672286-03-2
-
Formula Weight332.16
-
Molecular FormulaC11H7Cl2N3O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 100 mg/mL (301.06 mM)
-
SMILES[O-][N+](=O)c1cc(NC(=O)Nc2c(Cl)cccc2Cl)cs1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.S Moein Moghimi, et al. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Mol Ther. 2021 Mar 3;29(3):898-900.
molnova catalog
related products
-
DiD perchlorate
DiD perchlorate is a lipophilic cyanine dye that can be used in cells tracking.
-
Lithospermate B
Lithospermate B is a natural product activates eNOS and ameliorates endothelial dysfunction in diabetes by enhancing vasodilation in addition to reducing oxidative stress, it can protecte cardiomyocytes from ischemic injury through specific inhibition of TAB1-p38 apoptosis signaling.
-
β-Defensin-4, human
β-Defensin-4, human
Cart
sales@molnova.com